SB1536 Summary

• Amends section 32-1904 to delegate authority to the board's executive director to review prescription monitoring program information and report suspected unprofessional or illegal conduct to appropriate licensing boards or law enforcement.

• Requires the board to develop substantive policy statements for each delegated licensing and regulatory authority to the executive director.

• Amends section 36-2604 to expand "delegate" access to controlled substances prescription monitoring program data to include employees of the Arizona Health Care Cost Containment System and contractors authorized by the chief medical officer.

• Requires deactivation of delegates within five business days after employment status changes, delegate requests, or inappropriate use of the prescription monitoring system.

• Extends delegation authority to the executive director to review prescription information and notify appropriate professional boards or law enforcement agencies of suspected violations.